Apoptosis: Targets in pancreatic cancer

被引：119
作者：
Sabine Westphal
Holger Kalthoff
机构：
[1] Department of Molecular Oncology, Clinic for General/Thoracic Surgery, University of Kiel, 24105 Kiel
来源：
Molecular Cancer | / 2卷 / 1期
关键词：
Apoptosis; Oncologic therapies; Pancreatic cancer;
D O I：
10.1186/1476-4598-2-6
中图分类号：
学科分类号：
摘要：
Pancreatic adenocarcinoma is characterized by poor prognosis, because of late diagnosis and lack of response to chemo- and/or radiation therapies. Resistance to apoptosis mainly causes this insensitivity to conventional therapies. Apoptosis or programmed cell death is a central regulator of tissue homeostasis. Certain genetic disturbances of apoptotic signaling pathways have been found in carcinomas leading to tumor development and progression. In the past few years, the knowledge about the complex pathways of apoptosis has strongly increased and new therapeutic approaches based on this knowledge are being developed. This review will focus on the role of apoptotic proteins contributing to pancreatic cancer development and progression and will demonstrate possible targets to influence this deadly disease. © 2003 Westphal and Kalthoff; licensee BioMed Central Ltd.
引用
收藏
页数：14
相关论文
共 160 条
[91]  
McEleny K.R., Watson R.W., Coffey R.N., O'Neill A.J., Fitzpatrick J.M., Inhibitors of apoptosis proteins in prostate cancer cell lines, Prostate, 51, pp. 133-140, (2002)
[92]  
Li F., Ambrosini G., Chu E.Y., Plescia J., Tognin S., Marchisio P.C., Altieri D.C., Control of apoptosis and mitotic spindle checkpoint by survivin, Nature, 396, pp. 580-583, (1998)
[93]  
Tamm I., Wang Y., Sausville E., Scudiero D.A., Vigna N., Oltersdorf T., Reed J.C., IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs, Cancer Res., 58, pp. 5315-5320, (1998)
[94]  
Ambrosini G., Adida C., Altieri D.C., A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma, Nat. Med., 3, pp. 917-921, (1997)
[95]  
Yamamoto T., Tanigawa N., The role of survivin as a new target of diagnosis and treatment in human cancer, Med. Electron. Microsc., 34, pp. 207-212, (2001)
[96]  
Adida C., Berrebi D., Peuchmaur M., Reyes-Mugica M., Altieri D.C., Anti-apoptosis gene, survivin, and prognosis of neuroblastoma, Lancet, 351, pp. 882-883, (1998)
[97]  
Kawasaki H., Altieri D.C., Lu C.D., Toyoda M., Tenjo T., Tanigawa N., Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer, Cancer Res., 58, pp. 5071-5074, (1998)
[98]  
Lu C.D., Altieri D.C., Tanigawa N., Expression of novel anti-apoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas, Cancer Res., 58, pp. 1808-1812, (1998)
[99]  
Satoh K., Kaneko K., Hirota M., Masamune A., Satoh A., Shimosegawa T., Expression of survivin is correlated with cancer cell apoptosis and is involved in the development of human pancreatic duct cell tumors, Cancer, 92, pp. 271-278, (2001)
[100]  
Verhagen A.M., Ekert P.G., Pakusch M., Silke J., Connolly L.M., Reid G.E., Moritz R.L., Simpson R.J., Vaux D.L., Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins, Cell, 102, pp. 43-53, (2000)
567891011121314